Manipulation, and cryopreservation of autologous peripheral blood stem cell products in Italy: A survey by GITMO, SIDEM and GIIMA societies

被引:12
作者
Lanza, F. [1 ]
Mangianti, S. [2 ]
Accorsi, P. [3 ]
Lombardini, L. [4 ]
Martino, M. [5 ]
Saccardi, R. [6 ]
Vassanelli, A. [7 ]
Ostuni, A. [8 ]
Ciceri, F. [9 ]
机构
[1] Romagna Transplant Network, Ravenna, Italy
[2] Cell Proc Lab PS Cesena, Cesena, Italy
[3] Dept Oncohematol Transfus Serv, Genoa, Italy
[4] Italian Natl Transplant Ctr CNT, Rome, Italy
[5] Transplantat Unit, Reggio Di Calabria, Italy
[6] TranplantationUnit, Florence, Italy
[7] AOUI Verona, Transfus Med Dept, Verona, Italy
[8] Transfus Serv, Bari, Italy
[9] IRCCS San Raffaele Univ Hosp Milan, Milan, Italy
关键词
Stem cells; CD34; counting; Graft manipulation; Peripheral blood; Stem cell storage; VIABLE CD34(+) CELLS; ENGRAFTMENT; DISPOSAL; QUALITY; TRANSPLANTATION; REQUIREMENTS; ENUMERATION; POLICY;
D O I
10.1016/j.transci.2020.102753
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is considerable heterogeneity in manipulation and cryopreservation of hematopoietic stem cells (HSC) for autologous HSC transplantation across Europe and Italy. To better address this point, three Italian Scientific Societies (GITMO-Gruppo Italiano per il Trapianto di Midollo Osseo; SIDEM-Societa Italiana Emaferesi e Manipolazione Cellulare; and GIIMA-Gruppo Italiano Interdisciplinare Manipolazione e Aferesi per Terapie Cellulari), in collaboration with the Competent Authority "National Transplant Center" (CNT) sent to 85 Italian transplant centers (TC) a survey, which included 12 questions related to the most critical elements in graft processing. Fifty-nine centers (70 %) responded to the questionnaire. Overall, this survey demonstrates that the majority (>90 %) of responding TC used standardized procedures for HSC processing; however, an intercenter heterogeneity was clearly documented in several standard operating procedures adopted by different TC. These results seem to suggest that further standardization and efforts are needed to provide recommendations and guidelines on HSC manipulation, cryopreservation and functional assessment of cryopreserved material for autologous HSCT
引用
收藏
页数:4
相关论文
共 21 条
[1]   Number of viable CD34+ cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation [J].
Allan, DS ;
Keeney, M ;
Howson-Jan, K ;
Popma, J ;
Weir, K ;
Bhatia, M ;
Sutherland, DR ;
Chin-Yee, IH .
BONE MARROW TRANSPLANTATION, 2002, 29 (12) :967-972
[2]   Ten years after the first inspection of a candidate European centre, an EBMT registry analysis suggests that clinical outcome is improved when hematopoietic SCT is performed in a JACIE accredited program [J].
Chabannon, C. ;
Pamphilon, D. ;
Vermylen, C. ;
Gratwohl, A. ;
Niederwieser, D. ;
McGrath, E. ;
Lamers, C. ;
Lanza, F. ;
Slaper-Cortenbach, I. ;
Madrigal, A. ;
Apperley, J. .
BONE MARROW TRANSPLANTATION, 2012, 47 (01) :15-17
[3]   Pre infusion, post thaw CD34+ peripheral blood stem cell enumeration as a predictor of haematopoietic engraftment in autologous haematopoietic cell transplantation [J].
D'Rozario, James ;
Parisotto, Robin ;
Stapleton, Jennifer ;
Gidley, Alison ;
Owen, David .
TRANSFUSION AND APHERESIS SCIENCE, 2014, 50 (03) :443-450
[4]   Handling, processing and disposal of stem cell products in Europe: A survey by the cellular therapy and immunobiology working party of the European Society for Blood and Marrow Transplantation [J].
Holbro, Andreas ;
Baldomero, Helen ;
Lanza, Francesco ;
Chabannon, Christian ;
Snowden, John A. ;
Buser, Andreas ;
Infanti, Laura ;
Worel, Nina ;
Sureda, Anna ;
Badoglio, Manuela ;
Passweg, Jakob ;
Bonini, Chiara .
CYTOTHERAPY, 2018, 20 (03) :453-460
[5]  
Keeney M, 2003, J BIOL REG HOMEOS AG, V17, P247
[6]  
Lanza F, 2001, J BIOL REG HOMEOS AG, V15, P1
[7]   A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach [J].
Lanza, Francesco ;
Saraceni, Francesco ;
Pezzi, Annalisa ;
Martino, Massimo ;
Bosi, Alberto ;
Cascavilla, Nicola ;
Musto, Pellegrino ;
Zuffa, Eliana ;
Tani, Monica ;
Cellini, Claudia ;
Laszlo, Daniele ;
Bonifazi, Francesca .
AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (09) :E557-E559
[8]   Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphoma [J].
Lanza, Francesco ;
Lemoli, Roberto M. ;
Olivieri, Attilio ;
Laszlo, Daniele ;
Martino, Massimo ;
Specchia, Giorgina ;
Pavone, Vincenzo ;
Imola, Manuela ;
Pasini, Annalisa ;
Milone, Giuseppe ;
Scortechini, Ilaria ;
Todisco, Elisabetta ;
Guggiari, Elena ;
Cascavilla, Nicola ;
Martinelli, Giovanni ;
Rambaldi, Alessandro ;
Bosi, Alberto .
TRANSFUSION, 2014, 54 (02) :331-339
[9]   Individual Quality Assessment of Autografting by Probability Estimation for Clinical Endpoints: A Prospective Validation Study from the European Group for Blood and Marrow Transplantation [J].
Lanza, Francesco ;
Campioni, Diana C. ;
Hellmann, Andrzej ;
Milone, Giuseppe ;
Wahlin, Anders ;
Walewski, Jan ;
Spedini, Pierangelo ;
Fiamenghi, Cristina ;
Cuneo, Antonio ;
Knopinska, Wanda ;
Swierkowska-Czeneszew, Monica ;
Petriz, Jordi ;
Fruehauf, Stefan ;
Farge, Dominique ;
Mohty, Mohamad ;
Passweg, Jacob ;
Ruuto, Tapani ;
Madrigal, Alejandro ;
Johnsen, Hans E. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (12) :1670-1676
[10]   Essential requirements for setting up a stem cell processing laboratory [J].
Leemhuis, T. ;
Padley, D. ;
Keever-Taylor, C. ;
Niederwieser, D. ;
Teshima, T. ;
Lanza, F. ;
Chabannon, C. ;
Szabolcs, P. ;
Bazarbachi, A. ;
Koh, M. B. C. .
BONE MARROW TRANSPLANTATION, 2014, 49 (08) :1098-1105